Abstract:Introduction: Glioblastoma is resistant to adjuvant therapies due to the existence of a small fraction of tumor cells endowed with stem cell characteristics, namely, the glioma stem cells. Glioma stem cells reside in niches supporting their stemness maintenance, among which hypoxia and endothelial cells constitute the major components. Although there are evidences suggesting an interaction between hypoxia and endothelial cells, it is not clear how the two microenviromental factors are orchestrated to affect glioma stem cell phenotypes, especially given the findings that the necrosis and newly-formed vasculature in glioblastoma represent separate zones in situ. We used an in vitro model based on transwell system to cipher the co-effect of hypoxia and endothelial cells on glioma stem cell phenotypes. Materials and Methods: Transwell plates with 0.4 μm and 8 μm pore polycarbonate membrane inserts were utilized for co-culture and migration system. Human glioma stem cells and endothelial cells were seeded into the upper and lower chambers separately and kept under 1.5% O2 (hypoxia) or 20% O2 (normoxia) for 4-7 days. Temozolomide, CD133 staining and limiting dilution assay were used for determination of the stemness phenotypes. Wnt antibody and inhibitor Dkk were used to detect Wnt expression and block its function. Human glioblastoma sections stained with Nestin antibody showed the spatial distribution of glioma stem cells across the necrotic and vascular areas in situ. Results: Co-culture of glioma stem cells and endothelial cells under hypoxia showed no synergistic effect on stemness characteristics, while sequential treatment with hypoxia followed by normoxic co-culture with endothelial cells resulted in notably enhanced glioma stem cell phenotypes. Human glioblastoma tissue sections manifested a prominent aggregation of Nestin-positive cells around newly formed arterioles away from necrosis, implying cell migration from necrotic to vascularized areas. The transwell assay demonstrated a remarkable migration of hypoxic glioma stem cells towards endothelial cells compared to the control. Similar result has not yet been observed with glioma stem cells under normoxia condition. Surprisingly, the migrated cells which had direct contact with the endothelial cells showed decreased CD133 expression and spheroid formation ability compared with the cells non-migrated. Furthermore, Wnt level in glioma stem cells was elevated after hypoxia treatment and Wnt inhibitor Dkk could block the cell migration. Conclusions: Our study suggested migration of glioma stem cells from necrosis to endothelial cells upon hypoxic stimuli with Wnt pathway involved, and the sequential process from hypoxic condition to endothelial contacting modified glioma stem cell phenotypes. In vivo animal model and the role of the sequential niche conditioning in tumor progression are warranted for further study.

VEGF and Bcl-2 Interact Via MAPKs Signaling Pathway in the Response to Hypoxia in Neuroblastoma

Hypoxia stabilizes microtubule networks and decreases tumor cell chemosensitivity to anticancer drugs through Egr-1.

Hypoxia Promotes Etoposide (VP-16) Resistance in Neuroblastoma CHP126 Cells.

Anti-Vegf Treatment Interacts With Hypoxia-Driven Vascular Endothelial Growth Factor Loop Sensitivates Hepatoma Carcinoma Cells To Etoposide

Molecular responses to hypoxia in tumor cells

Hypoxia-Induced Vasculogenic Mimicry Formation Via Ve-Cadherin Regulation by Bcl-2

Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.

Upregulation Of Hif-1 Alpha By Hypoxia Protect Neuroblastoma Cells From Apoptosis By Promoting Survivin Expression

Targeting Hypoxia and HIF1α in Triple-Negative Breast Cancer: New Insights from Gene Expression Profiling and Implications for Therapy

Tumor hypoxia promotes MAPK signaling by inhibiting prolyl hydroxylation of SOS1

Effects of Hypoxia on Proliferation and Apoptosis of Osteosarcoma Cells

Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy.

Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways

Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma

Data from Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1α

Upregulation of HIF-1 alpha protects neuroblastoma cells from hypoxia-induced apoptosis in a RhoA-dependent manner

Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming

P08.63 Hypoxia and Endothelial Cells Sequentially, but Not Synergistically, Affected Glioma Stem Cell Phenotypes Implying an in Vivo Cell Migration from Necrotic to Vascularized Areas with Wnt Pathway Involved

ERK/MAPK Activation Involves Hypoxia‐induced MGr1‐Ag/37LRP Expression and Contributes to Apoptosis Resistance in Gastric Cancer

Hypoxia Influences Linearly Patterned Programmed Cell Necrosis and Tumor Blood Supply Patterns Formation in Melanoma

Increased oxygen stimulation promotes chemoresistance and phenotype shifting through PLCB1 in gliomas